Pär Comstedt | VP Infectious Disease Vaccine Development
Evaxion Biotech A/S

Pär Comstedt, PhD, is Vice President of Infectious Disease Vaccines at Evaxion. He leads the company’s portfolio of bacterial and viral vaccine programs, developed through the proprietary AI-immunology platform. With 20 years of experience in vaccine R&D, Pär has contributed across discovery, preclinical, and nonclinical development. Before joining Evaxion, he worked at Valneva, where he led the preclinical activities of the Lyme disease vaccine program VLA15, now in phase 3 in partnership with Pfizer.